Skip to main content

Peer Review reports

From: The key role of Shenyan Kangfu tablets, a Chinese patent medicine for diabetic nephropathy: study protocol for a randomized, double-blind and placebo-controlled clinical trial

Original Submission
22 Feb 2013 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
13 Apr 2013 Author responded Author comments - hui wang
Resubmission - Version 4
13 Apr 2013 Submitted Manuscript version 4
26 Apr 2013 Author responded Author comments - hui wang
Resubmission - Version 5
26 Apr 2013 Submitted Manuscript version 5
Publishing
9 May 2013 Editorially accepted
5 Jun 2013 Article published 10.1186/1745-6215-14-165

You can find further information about peer review here.

Back to article page

Trials

ISSN: 1745-6215